Notice of expiration of PA-18-626 "NIDA Small Research Grant Program (R03 Clinical Trial Required)"

Notice Number: NOT-DA-18-008

Key Dates
Release Date: February 21, 2018

Related Announcements
PA-18-626
  PA-18-634

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

This Notice informs the community that the NIDA Small Research Grant Program (R03 Clinical Trial Required) funding opportunity announcement was inadvertently posted twice under two different opportunity numbers – PA-18-626 and PA-18-634. The first due date for this opportunity is June 18, 2018.
 
To address the duplication issue, we have expired PA-18-626 effective immediately.  Applicants who wish to apply to the NIDA Small Research Grant Program (R03 Clinical Trial Required) opportunity MUST use PA-18-634.

Note: ASSIST, Workspace and many institutional system-to-system solutions allow application data to be easily copied from one opportunity or application package to another. If you started an application using PA-18-626 and need assistance moving your data to PA-18-634, contact the appropriate support team for assistance (ASSIST – eRA Service Desk; Workspace – Grants.gov Contact Center).

Inquiries

Please direct all inquiries to:

Guifang Lao, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-5931
Email: laog@nida.nih.gov

Vani Pariyadath, Ph.D.
National Institute on Drug Abuse (NIDA)
Division of Neuroscience and Behavior
Telephone: 301-443-3209
Email: vani.pariyadath@nih.gov

Samia Noursi, Ph.D.
National Institute on Drug Abuse (NIDA)
Division of Epidemiology, Services and Prevention Research
Telephone: 301-594-5622
Email: snoursi@nida.nih.gov